Drugs / [68Ga]Ga-NOTA-exendin-4
[68Ga]Ga-NOTA-exendin-4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05034783 | Oct 2021 → Oct 2022 | pancreatic insulinoma | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [68Ga]Ga-NOTA-exendin-4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05034783 ↗ |
| Modality | Diagnostic / imaging agent | “GLP-1R-targeted PET agent” PMID 39499011 ↗ Nov 2024 |
| Route | Intravenous | “Intravenous injection” NCT05034783 ↗ |